SmartestCrowd
Organizations
Orgs
No organizations
Projects
No projects
0
0
BioMarin to Buy Rare-Disease Biotech Amicus Therapeutics for $4.8 Billion - The Wall Street Journal
12/19/25 at 4:57pm
Organization
The Wall Street Journal
Author
The Wall Street Journal
16 words
0
Comments
Business & Industrial
You are the first to view
https://www.wsj.com/business/deals/biomarin-to-buy-amicus-therapeutics-for-4-8-billion-c338bf7d
Create an account
or
login
to join the discussion
Modal title
...
Profile
Loading profile
Loading...